Back to discover
Drug

Isoleucine

Research stage
Emerging research
Also known as (2S,3S)-2-Amino-3-methylpentanoic acid, 2-Amino-3-methylvaleric acid, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free+42 more

(2S,3S)-2-Amino-3-methylpentanoic acid, 2-Amino-3-methylvaleric acid, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5%, Sulfite-Free, Aminosyn II 10 %, Aminosyn II 15%, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, Branchamin, Clinisol 15, Freamine III 10, Hepatamine 8, Hepatasol, Ile, Ile - Isoleucine, L-Isoleucine, Nephramine, Plenamine, PremaSol, ProSol, ProcalAmine 3, Travasol 10, Travasol 10%, Trophamine, Trophamine 10 %, Trophamine 6 %, alpha-amino-beta-methylvaleric acid, Isoleucina, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25, Isoleucinum.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Isoleucine
Aliases & brands
(2S,3S)-2-Amino-3-methylpentanoic acid2-Amino-3-methylvaleric acidAminosyn 10%, Sulfite-FreeAminosyn 3.5 % M, Sulfite FreeAminosyn 8.5 % with Electrolytes, Sulfite-FreeAminosyn 8.5%, Sulfite-FreeAminosyn II 10 %Aminosyn II 15%Aminosyn II 8.5 % with Electrolytes, Sulfite-FreeAminosyn II 8.5 %, Sulfite-FreeAminosyn-HBC 7 %, Sulfite-FreeAminosyn-PF 10 %, Sulfite-FreeAminosyn-PF 7%BranchaminClinisol 15Freamine III 10Hepatamine 8HepatasolIleIle - IsoleucineL-IsoleucineNephraminePlenaminePremaSolProSolProcalAmine 3Travasol 10Travasol 10%TrophamineTrophamine 10 %Trophamine 6 %alpha-amino-beta-methylvaleric acidIsoleucinaClinimix 4.25/10Clinimix 4.25/25Clinimix 4.25/5Clinimix 5/15Clinimix 5/20Clinimix 5/25Clinimix E 2.75/5Clinimix E 4.25/10Clinimix E 4.25/5Clinimix E 5/15Clinimix E 5/20Clinimix E 5/25Isoleucinum
RxNorm CUI
6033
ChEMBL ID
CHEMBL1233584
UNII
04Y7590D77

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • Cell research1
Leading researchers
  • Chang S1
  • Chu X1
  • Ding J1
  • Du C1
  • Feng T1
  • Ge C1
  • Geng M1
  • Gong Y1
Leading institutions
free-text, unnormalised
  • Institutional Technology Service Center1
  • Shanghai Mental Health Center1
  • State Key Laboratory of Drug Research1

Related drugs

4 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 3 of the same disease areas as Isoleucine in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Isoleucine in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Isoleucine in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Isoleucine in the shared literature.

3 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature